Honey is not a remedy for insulin resistance, but in small amounts it may be a slightly better option than table sugar or other sweeteners. The evidence is mixed: lab studies show promising biological effects, while human trials have found little measurable improvement in insulin resistance markers. The real answer depends on how much you consume and what you’re replacing it with.
What Human Trials Actually Show
The most direct way to measure insulin resistance is a score called HOMA-IR. In a randomized crossover trial of people with type 2 diabetes, eight weeks of honey consumption produced a small, non-significant drop in HOMA-IR (from 2.22 to 1.9). Fasting insulin also dipped slightly, but again, the change wasn’t statistically meaningful. When researchers compared the honey group to the control group, there was no significant difference in fasting blood glucose, insulin levels, or any marker of insulin resistance.
A large meta-analysis of 69 randomized controlled trials with over 3,500 participants found that roughly 10 grams of honey per day (about half a tablespoon) may modestly lower HbA1c, a measure of long-term blood sugar control. But here’s the catch: higher amounts of honey actually raised HbA1c, along with fasting blood glucose, triglycerides, and markers of inflammation. The dose makes a significant difference, and the window of potential benefit is narrow.
How Honey Affects Blood Sugar Differently Than Sugar
Honey is roughly 40% fructose and 30% glucose, with the exact ratio varying by variety. That fructose-to-glucose ratio matters because fructose is processed primarily by the liver rather than spiking blood sugar directly. In the liver, fructose activates an enzyme that helps store glucose as glycogen, effectively pulling some sugar out of your bloodstream. The glucose naturally present in honey actually helps this process by improving fructose absorption and delivery to the liver.
The glycemic index of honey falls around 69 to 74, depending on the variety. For comparison, pure glucose scores 100 and table sugar lands around 65. So honey sits in a similar range to table sugar in terms of blood sugar impact. A study testing four U.S. honey varieties (clover, buckwheat, cotton, and tupelo) found no significant differences in glycemic index between them, even though their fructose-to-glucose ratios varied. If you’ve heard that certain specialty honeys are dramatically better for blood sugar, the data doesn’t support that claim.
The Antioxidant Angle
Where honey does show genuine promise, at least in laboratory research, is through its antioxidant and anti-inflammatory compounds. Insulin resistance isn’t just about sugar. It develops partly because chronic inflammation and oxidative stress interfere with insulin signaling inside your cells. Inflammatory molecules activate pathways that essentially block your cells from responding to insulin properly.
Honey contains phenolic compounds like quercetin, caffeic acid, and gallic acid. In cell studies, these compounds reduced the activity of two key inflammatory pathways (JNK and IKK-β) that drive insulin resistance. When pancreatic cells were exposed to high glucose levels, they ramped up production of inflammatory molecules like TNF-α and IL-6. Pretreating those cells with honey extract significantly reversed this, lowering inflammation and restoring a protein (Akt) that’s essential for insulin to work correctly.
Animal studies have shown that honey increased the expression of GLUT-4, a transporter protein that moves glucose from your blood into fat and muscle cells. More GLUT-4 activity means better insulin sensitivity. These are encouraging biological effects, but it’s important to note that cell and animal studies don’t always translate to meaningful changes in living humans, which is consistent with the modest results seen in clinical trials.
The Fructose Problem at Higher Doses
One reason larger amounts of honey can backfire is its fructose content. In small quantities, fructose supports liver glycogen storage. In larger quantities, it overwhelms that system and triggers a process called de novo lipogenesis, where the liver starts converting excess fructose into fat. This raises triglyceride levels and can worsen the very metabolic dysfunction you’re trying to address. Several clinical trials that reported negative metabolic effects from honey were likely seeing the consequences of added calories and fructose load rather than anything specific to honey itself.
This is the core tension with honey and insulin resistance. The antioxidants work in your favor, but the sugar content works against you, and the sugar content is far greater by weight. Honey is still roughly 80% sugar. Any metabolic benefit from its phenolic compounds can easily be canceled out by consuming too much of it.
Practical Guidelines for Using Honey
If you’re insulin resistant or prediabetic, the most useful way to think about honey is as a replacement, not an addition. Swapping out table sugar, agave, or maple syrup for a small amount of honey gives you roughly the same sweetness with a modest antioxidant bonus, but adding honey on top of your existing sugar intake will raise your blood sugar and calorie load.
The research points to about half a tablespoon (10 grams) daily as the upper limit where any benefit might exist. That’s roughly one thin drizzle on yogurt or in tea. Beyond that amount, the metabolic markers in studies consistently moved in the wrong direction. For context, a typical squeeze-bottle serving of honey is about 21 grams, already double the amount that showed any potential benefit.
Raw, unprocessed honey retains more of its phenolic compounds than commercially processed varieties, which are often heated and filtered in ways that reduce antioxidant content. The specific floral source (clover vs. buckwheat vs. manuka) matters less for blood sugar impact than many marketing claims suggest, since glycemic index values are similar across varieties. What matters most is the amount you use.